Impact of the SARS-CoV-2 nucleocapsid 203K/204R mutations on the inflammatory immune response in COVID-19 severity.

MLA

Shuaib, Muhammad, et al. “Impact of the SARS-CoV-2 Nucleocapsid 203K/204R Mutations on the Inflammatory Immune Response in COVID-19 Severity.” Genome Medicine, vol. 15, no. 1, July 2023, pp. 1–16. EBSCOhost, https://doi.org/10.1186/s13073-023-01208-0.

APA

Shuaib, M., Adroub, S., Mourier, T., Mfarrej, S., Zhang, H., Esau, L., Alsomali, A., Alofi, F. S., Ahmad, A. N., Shamsan, A., Khogeer, A., Hashem, A. M., Almontashiri, N. A. M., Hala, S., & Pain, A. (2023). Impact of the SARS-CoV-2 nucleocapsid 203K/204R mutations on the inflammatory immune response in COVID-19 severity. Genome Medicine, 15(1), 1–16. https://doi.org/10.1186/s13073-023-01208-0

Chicago

Shuaib, Muhammad, Sabir Adroub, Tobias Mourier, Sara Mfarrej, Huoming Zhang, Luke Esau, Afrah Alsomali, et al. 2023. “Impact of the SARS-CoV-2 Nucleocapsid 203K/204R Mutations on the Inflammatory Immune Response in COVID-19 Severity.” Genome Medicine 15 (1): 1–16. doi:10.1186/s13073-023-01208-0.